On June 28, 2023, Dr. Trieu purchased 75,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.026. Further, on June 29, 2023, Dr. Trieu purchased 425,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.021.